Regional lymph node assessment for conjunctival melanoma: Sentinel lymph node biopsy and positron emission tomography

British Journal of Ophthalmology

Volumn 92, Issue 4, 2008, Pages 443-445

  Esmaeli, Bita ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M;

CANCER INCIDENCE; CANCER RADIOTHERAPY; CONJUNCTIVA; CONJUNCTIVAL MELANOMA; EYE TUMOR; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MELANOMA; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY;

CONJUNCTIVAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; SENTINEL LYMPH NODE BIOPSY;

EID: 41849091882     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.131615     Document Type: Review

References (22)

1. Seregard S, Koch E. Conjunctival malignant melanoma in Sweden 1969-91. Acta Ophthalmol 1992;70:289-96.
2. Esmaeli B, Wang X, Youssef A, et al. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology 2001;108:2101-5.
3. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma. Risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000;118:1497-507.
4. Lim M, Tatla T, Hersh D, et al. Patterns of regional head and neck lymph node metastasis in primary conjunctival malignant melanoma. Br J Ophthalmol 2006;90:1468-71.
5. Tuomaala S, Kivelä T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 2004;111:816-21.
6. Werschnik C, Lommarzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol 2002;25:248-55.
7. Esmaeli B. Sentinel lymph node mapping for patients with cutaneous and conjunctival malignant melanoma. Ophthal Plast Heconstr Surg 1999;16:170-2.
8. Wilson MW, Fleming JC, Fleming RM, et al. Sentinel node biopsy for orbital and ocular adnexal tumors [discussion 344-5]. Ophthal Plast Reconstr Surg 2001;17:338-44.
9. Amato M, Esmaeli B, Ahmadi MA, et al. Feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph nodes in patients with conjunctival and periocular skin malignancies. Ophthal Plast Reconstr Surg 2002;19:102-6.
10. Esmaeli B, Reifler D, Prieto VG, et al. Conjunctival melanoma with a positive sentinel lymph node. Arch Ophthalmol 2003;121:1779-83.
11. Nijhawan N, Ross MI, Diba R, et al. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg 2004;20:291-5.
12. Baroody M, Holds JB, Kokoska MS, et al. Conjunctival melanoma metastasis diagnosed by sentinel lymph node biopsy. Am J Ophthalmol 2004;137:1147-9.
13. Ho VH, Ross MI, Prieto VG, et al. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg 2007;133:820-6.
14. Kurli M, Chin K, Finger PT. Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma. Br J Ophthalmol 2008;92:479-82.
15. Morton DL, Wen DR, Wong JH, et al. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
16. Esmaeli B. Sentinel node biopsy as a tool for accurate staging of eyelid and conjunctival malignancies. Curr Opin Ophthalmol 2002;13:317-23.
17. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I and II melanoma patients. J Clin Oncol 1999;17:976-83.
18. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307-17.
19. Esmaeli B. Disseminated conjunctival melanoma [author reply 2317-8]. Ophthalmology 2004;111:2317.
20. Puleo CA, Messina JL, Riker AI, et al. Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control 2005;12:230-5.
21. Wagner JD, Schauwecker D, Davidson D, et al. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma. Cancer 2005;104:570-9.
22. Horn J, Lock-Andersen J, Sjostrand H, et al. Routine use of FDG-PET scans in melanoma pateints with positive sentinel node biopsy. Eur J Nucl Med Mol Imaging 2006;33:887-92.